Who are Prelone's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): prednisolon, Medrol, Methylprednisolone (drug), Methylprednisolone Injectable Product, Decadron Phosphate, Injectable, Dexamethasone physician choice.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/prednisolone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Prelone — Competitive Intelligence Brief

Prelone (prednisolone) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Glucocorticoid (corticosteroid). Area: Oncology.

marketed Glucocorticoid (corticosteroid) Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1 Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Prelone (prednisolone) — Generic (originally Schering).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Prelone TARGET	prednisolone	Generic (originally Schering)	marketed	Glucocorticoid (corticosteroid)	Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1	1955-01-01
prednisolon	prednisolon	Hannover Medical School	marketed		Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1
Medrol	methylprednisolone	Generic (originally Upjohn/Pfizer)	marketed	Glucocorticoid (corticosteroid)	Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor	1957-10-01
Methylprednisolone (drug)	Methylprednisolone (drug)	University Hospital, Bordeaux	marketed	Glucocorticoid (corticosteroid)	Glucocorticoid receptor (GR)
Methylprednisolone Injectable Product	Methylprednisolone Injectable Product	Vanderbilt University Medical Center	marketed	Glucocorticoid (corticosteroid)	Glucocorticoid receptor (GR)
Decadron Phosphate, Injectable	Decadron Phosphate, Injectable	Hospital for Special Surgery, New York	marketed	Glucocorticoid (corticosteroid)	Glucocorticoid receptor (GR)
Dexamethasone physician choice	Dexamethasone physician choice	Ottawa Hospital Research Institute	marketed	Glucocorticoid (corticosteroid)	Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Glucocorticoid (corticosteroid) class)

Merck Sharp & Dohme LLC · 2 drugs in this class
The Children's Hospital of Zhejiang University School of Medicine · 2 drugs in this class
Vanderbilt University Medical Center · 2 drugs in this class
Fujian Shengdi Pharmaceutical Co., Ltd. · 1 drug in this class
Hamad Medical Corporation · 1 drug in this class
Hoffmann-La Roche · 1 drug in this class
Generic (originally Upjohn/Pfizer) · 1 drug in this class
Manuel Taboada Muñiz · 1 drug in this class
Masonic Cancer Center, University of Minnesota · 1 drug in this class
Hospital for Special Surgery, New York · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Prelone — Competitive Intelligence Brief. https://druglandscape.com/ci/prednisolone. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab